Skip to main content
Log in

Identification of a Novel Cleavage Site and Confirmation of the Effectiveness of NgAgo Gene Editing on RNA Targets

  • Original Paper
  • Published:
Molecular Biotechnology Aims and scope Submit manuscript

Abstract

Clusters of regularly interspaced short palindromic repeats (CRISPR)/Cas systems have a powerful ability to edit DNA and RNA targets. However, the need for a specific recognition site, protospacer adjacent motif (PAM), of the CRISPR/Cas system limits its application in gene editing. Some Argonaute (Ago) proteins have endonuclease functions under the guidance of 5′ phosphorylated or hydroxylated guide DNA (gDNA). The NgAgo protein might perform RNA gene editing at 37 °C, suggesting its application in mammalian cells; however, its mechanisms are unclear. In the present study, the target of NgAgo in RNA was confirmed in vitro and in vivo. Then, an in vitro RNA cleavage system was designed and the cleavage site was verified by sequencing. Furthermore, NgAgo and gDNA were transfected into cells to cleave an intracellular target sequence. We demonstrated targeted degradation of GFP, HCV, and AKR1B10 RNAs in a gDNA-dependent manner by NgAgo both in vitro and in vivo, but no effect on DNA was observed. Sequencing demonstrated that the cleavage sites are located at the 3′ of the target RNA which is recognized by 5′ sequence of the gDNA. These results confirmed that NgAgo–gDNA cleaves RNA not DNA. We observed that the cleavage site is located at the 3′ of the target RNA, which is a new finding that has not been reported in the past.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Doetschman, T., & Georgieva, T. (2017). Gene editing with CRISPR/Cas9 RNA-directed nuclease. Circulation Research, 120, 876–894.

    Article  CAS  Google Scholar 

  2. Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., et al. (2014). Genome-scale CRISPR-Cas9 knockout screening in human cells. Science, 343, 84.

    Article  CAS  Google Scholar 

  3. Doench, J. G., Nicolo, F., Meagan, S., Mudra, H., Vaimberg, E. W., et al. (2016). Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nature Biotechnology, 34, 184–191.

    Article  CAS  Google Scholar 

  4. Bin Moon, S., Lee, J. M., Kang, J. G., Lee, N. E., Ha, D. I., et al. (2018). Highly efficient genome editing by CRISPR-Cpf1 using CRISPR RNA with a uridinylate-rich 3’-overhang. Nature Communications, 9, 3651.

    Article  Google Scholar 

  5. Granadosriveron, J. T., & Aquinojarquin, G. (2018). CRISPR-Cas13 precision transcriptome engineering in cancer. Cancer Research, 78, 4107–4113.

    Article  CAS  Google Scholar 

  6. Swarts, D. C., Jore, M. M., Westra, E. R., Zhu, Y., Janssen, J. H., et al. (2014). DNA-guided DNA interference by a prokaryotic Argonaute. Nature, 507, 258–261.

    Article  CAS  Google Scholar 

  7. Swarts, D. C., Hegge, J. W., Hinojo, I., Shiimori, M., Ellis, M. A., et al. (2015). Argonaute of the archaeon Pyrococcus furiosus is a DNA-guided nuclease that targets cognate DNA. Nucleic Acids Research, 43, 5120–5129.

    Article  CAS  Google Scholar 

  8. Ryazansky, S., Kulbachinskiy, A., & Aravin, A. A. (2018). The expanded universe of prokaryotic argonaute proteins. MBio, 9, e01935-e2018.

    Article  Google Scholar 

  9. Wilson, R. C., & Doudna, J. A. (2013). Molecular mechanisms of RNA interference. Annual Review of Biophysics, 42, 217–239.

    Article  CAS  Google Scholar 

  10. Kobayashi, H., & Tomari, Y. (2016). RISC assembly: Coordination between small RNAs and Argonaute proteins. Biochimica et Biophysica Acta, 1859, 71–81.

    Article  CAS  Google Scholar 

  11. Meister, G. (2013). Argonaute proteins: Functional insights and emerging roles. Nature Reviews Genetics, 14, 447–459.

    Article  CAS  Google Scholar 

  12. Burgess, S., Cheng, L., Gu, F., Huang, J., Huang, Z., et al. (2016). Questions about NgAgo. Protein & Cell, 7, 913–915.

    Article  Google Scholar 

  13. Cai, M., Si, Y., Zhang, J., Tian, Z., & Du, S. (2018). Zebrafish embryonic slow muscle is a rapid system for genetic analysis of sarcomere organization by CRISPR/Cas9, but not NgAgo. Marine Biotechnology (New York, N.Y.), 20, 168–181.

    Article  CAS  Google Scholar 

  14. Javidi-Parsijani, P., Niu, G., Davis, M., Lu, P., Atala, A., et al. (2017). No evidence of genome editing activity from Natronobacterium gregoryi Argonaute (NgAgo) in human cells. PLoS ONE, 12, e0177444.

    Article  Google Scholar 

  15. Khin, N. C., Lowe, J. L., Jensen, L. M., & Burgio, G. (2017). No evidence for genome editing in mouse zygotes and HEK293T human cell line using the DNA-guided Natronobacterium gregoryi Argonaute (NgAgo). PLoS ONE, 12, e0178768.

    Article  Google Scholar 

  16. Lee, S. H., Turchiano, G., Ata, H., Nowsheen, S., Romito, M., et al. (2016). Failure to detect DNA-guided genome editing using Natronobacterium gregoryi Argonaute. Nature Biotechnology, 35, 17–18.

    Article  Google Scholar 

  17. Qi, J., Dong, Z., Shi, Y., Wang, X., Qin, Y., et al. (2016). NgAgo-based fabp11a gene knockdown causes eye developmental defects in zebrafish. Cell Research, 26, 1349–1352.

    Article  CAS  Google Scholar 

  18. Wu, Z., Tan, S., Xu, L., Gao, L., Zhu, H., et al. (2017). NgAgo-gDNA system efficiently suppresses hepatitis B virus replication through accelerating decay of pregenomic RNA. Antiviral Research, 145, 20–23.

    Article  CAS  Google Scholar 

  19. Ye, S., Taegeun, B., Kyoungmi, K., Omer, H., Hwan, L. S., et al. (2017). DNA-dependent RNA cleavage by the Natronobacterium gregoryi Argonaute. BioRxiv. https://doi.org/10.1101/101923

    Article  Google Scholar 

  20. Li, J., Guo, Y., Duan, L., Hu, X., Zhang, X., et al. (2017). AKR1B10 promotes breast cancer cell migration and invasion via activation of ERK signaling. Oncotarget, 8, 33694–33703.

    Article  Google Scholar 

  21. Wang, Q., He, R., Tan, T., Li, J., Hu, Z., et al. (2019). A novel long non-coding RNA-KAT7 is low expressed in colorectal cancer and acts as a tumor suppressor. Cancer Cell International, 19, 40.

    Article  CAS  Google Scholar 

  22. Hu, Z., Shi, Z., Guo, X., Jiang, B., Wang, G., et al. (2018). Ligase IV inhibitor SCR7 enhances gene editing directed by CRISPR-Cas9 and ssODN in human cancer cells. Cell & Bioscience, 8, 12.

    Article  Google Scholar 

  23. Lao, Y. H., Li, M., Gao, M. A., Shao, D., Chi, C. W., et al. (2018). HPV oncogene manipulation using nonvirally delivered CRISPR/Cas9 or Natronobacterium gregoryi Argonaute. Advanced Science (Weinh), 5, 1700540.

    Article  Google Scholar 

Download references

Acknowledgements

The authors are very grateful to Mr. Zhang Jian in the Translational Medicine Institute of the First People’s Hospital of Chen Zhou for his kind help with the GFP-positive cell analysis by flow cytometry.

Funding

This work was funded by the Hunan Province Science Fund for Distinguished Young Scholars (2018JJ1021), the Natural Science Foundation of Hunan Province (2017JJ2004), the Hunan Province Technological Innovation Guiding Plan, Clinical Medical Technology Innovation Guidance Project (2017SK51101), the Health Department project of the Hunan Province (B2017182, B20180378, B20180266, and C20180166), the Science and Technique Foundation of Chenzhou (jsyf2017021, jsyf2017023, and zdyf201838), the Key Projects of Chenzhou Science and Technology Foundation (zdyf2020008 and zdyf2020011), and the Project of Xiangnan University of 2017 to ZH.

Author information

Authors and Affiliations

Authors

Contributions

ZH, KL, and DXL conceived the study; JYQ, YLX, ZYG, XTL, JJ, TC, and ZH conducted the experiments; ZH, KL, and DXL analyzed the data; JYQ, YLX, and ZH wrote the paper; JYQ and ZH revised the manuscript. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Zheng Hu or Dixian Luo.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Qu, J., Xie, Y., Guo, Z. et al. Identification of a Novel Cleavage Site and Confirmation of the Effectiveness of NgAgo Gene Editing on RNA Targets. Mol Biotechnol 63, 1183–1191 (2021). https://doi.org/10.1007/s12033-021-00372-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12033-021-00372-1

Keywords

Navigation